<DOC>
	<DOCNO>NCT02418468</DOCNO>
	<brief_summary>This study compare efficacy indacaterol versus placebo COPD patient classify GOLD 2014 Patient Group B . This 2-arm parallel group study recruit COPD patient classify GOLD Patient Gorup B . On successful completion run-in period , patient randomize ratio 1:1 receive prn salbutamol plus : 1 . Indacaterol 150ug 2 . Placebo indacaterol od 26 week . The primary objective ( trough FEV1 ) assess 12 week .</brief_summary>
	<brief_title>Effects Indacaterol Symptomatic COPD Patients With Low Risk Exacerbations</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Inclusion criterion 1 . Male female adult age â‰¥40 year , provide consent sign Informed Consent Form . Written informed consent must obtain assessment perform . 2 . Patients diagnose COPD 40 year age old . 3 . Patients smoke history least 10 pack year , current exsmokers eligible . ( Ten pack year define 20 cigarette day 10 year , 10 cigarette day 20 year , etc ) 4 . Patients stable COPD Patient Group B accord GOLD 2014 . Exclusion criteria 1 . Use investigational drug within 5 halflives enrollment , [ within 30 day /until expect PD effect return baseline ] , whichever longer . 2 . History hypersensitivity study drug drug similar chemical class . 3 . Pregnant nursing ( lactate ) woman , pregnancy define state female conception termination gestation , confirm positive hCG laboratory test . 4 . Patients 2 COPD exacerbation require treatment antibiotic , systemic steroid ( oral intravenous ) 1 exacerbation result hospitalization 12 month prior Visit 1 . 5 . Patients COPD exacerbation infection 6 week prior Visit 1 . 6 . Patients develop moderate severe COPD exacerbation period Visit 1 Visit 2 . 7 . Patients history asthma .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>COPD , FEV1 , indacaterol</keyword>
</DOC>